Item 2.02 Results of Operations and Financial Condition.

On May 13, 2020, Allena Pharmaceuticals, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2020 and provided a business update. The full text of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

The information under this Item 2.02 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits




Exhibit
  No.      Description

99.1         Press release of Allena Pharmaceuticals, Inc. (concerning financial
           results) dated May 13, 2020, furnished hereto.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses